| JXHL1600100 | 奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2016-08-31 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2017-01-20 | view |
| JXHL1600101 | 奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2016-08-31 | AstraZeneca AB | AstraZeneca AB | Certificate Issued | 2017-01-20 | view |
| JTH2100638 | 奥希替尼薄膜衣片 | osimertinib mesylate | Tablet | Chemical Drugs | Disposable Import Drug Application | 2021-09-03 | | | | | view |
| JXHB2200040 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2022-03-24 | | AstraZeneca AB | | | view |
| JYHB2002228 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2020-11-05 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2020-11-24 | view |
| JYHB1800012 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2018-01-12 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Approval Completed-Pending Certificated | 2018-02-01 | view |
| JYHB2300485 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2023-08-29 | | AstraZeneca AB | | | view |
| JYHB2101571 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-12-09 | | AstraZeneca AB | | | view |
| JXHS1800054 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2018-10-29 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-09-03 | view |
| JYHB2400005 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2024-01-04 | | AstraZeneca AB | | | view |
| JYHZ2100526 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | License Renew | 2021-04-23 | | | | | view |
| JYHB2001171 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-07-04 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-09-04 | view |
| JYHB1701074 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs | Supplementary Application | 2017-08-21 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-02-13 | view |
| JYHB2101572 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-12-09 | | AstraZeneca AB | | | view |
| JYHB2100140 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2021-02-20 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2021-09-23 | view |
| JXHL1800075 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2018-07-09 | | AstraZeneca AB | Certificate Issued | 2018-09-04 | view |
| JXHL2300319 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2023-12-22 | | | | | view |
| JYHZ2100525 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | License Renew | 2021-04-23 | | | | | view |
| JYHB2000291 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2020-04-01 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-05-25 | view |
| JYHB2400368 | 甲磺酸奥希替尼片 | osimertinib mesylate | Tablet | Chemical Drugs(5.1) | Supplementary Application | 2024-07-17 | | AstraZeneca AB | | | view |
